By Michael Smith , North American Correspondent, MedPage Today
Published: November 01, 2010
BOSTON -- The possibility of making even the most refractory subtypes of hepatitis C routinely curable is coming closer, a prominent researcher said in this exclusive InFocus interview.
Arun Sanyal, MD, president of the American Association for the Study of Liver Diseases, reviewed some of the new data with MedPage Today North American Correspondent Michael Smith at the association's annual meeting. As part of the discussion, Sanyal explained why he thinks hepatitis C will soon be a "winnable" disease.
Source
No comments:
Post a Comment